{"id":724,"date":"2024-01-19T21:04:10","date_gmt":"2024-01-19T21:04:10","guid":{"rendered":"https:\/\/gebro.es\/?p=724"},"modified":"2024-06-21T09:09:21","modified_gmt":"2024-06-21T09:09:21","slug":"ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables","status":"publish","type":"post","link":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/","title":{"rendered":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d"},"content":{"rendered":"\n<p>El pasado mes de enero Sergi Aulinas, CEO de Gebro Pharma, realiz\u00f3 una entrevista con el peri\u00f3dico econ\u00f3mico Cinco D\u00edas. En ella cuenta un reciente relanzamiento de un producto de la compa\u00f1\u00eda, hecho posible gracias a un acuerdo coinversiones. Aulinas se\u00f1ala los desaf\u00edos en el acceso a nuevos medicamentos y aboga por una sanidad p\u00fablica de calidad.<\/p>\n\n\n\n<p>Lee la noticia completa <a href=\"https:\/\/cincodias.elpais.com\/extras\/ciencia-salud\/2024-01-19\/sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables.html\" target=\"_blank\" rel=\"noreferrer noopener\">aqu\u00ed.<\/a><br><\/p>\n\n\n\n<p><br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pasado mes de enero Sergi Aulinas, CEO de Gebro Pharma, realiz\u00f3 una entrevista con el peri\u00f3dico econ\u00f3mico Cinco D\u00edas. En ella cuenta un reciente relanzamiento de un producto de la compa\u00f1\u00eda, hecho posible gracias a un acuerdo coinversiones. Aulinas se\u00f1ala los desaf\u00edos en el acceso a nuevos medicamentos y aboga por una sanidad p\u00fablica [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":502,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-724","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma\" \/>\n<meta property=\"og:description\" content=\"El pasado mes de enero Sergi Aulinas, CEO de Gebro Pharma, realiz\u00f3 una entrevista con el peri\u00f3dico econ\u00f3mico Cinco D\u00edas. En ella cuenta un reciente relanzamiento de un producto de la compa\u00f1\u00eda, hecho posible gracias a un acuerdo coinversiones. Aulinas se\u00f1ala los desaf\u00edos en el acceso a nuevos medicamentos y aboga por una sanidad p\u00fablica [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/\" \/>\n<meta property=\"og:site_name\" content=\"Gebro Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-19T21:04:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-21T09:09:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"384\" \/>\n\t<meta property=\"og:image:height\" content=\"476\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mortensen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mortensen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/\"},\"author\":{\"name\":\"mortensen\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#\\\/schema\\\/person\\\/3fddcc01f48c9153acc62fa1fb9c3a78\"},\"headline\":\"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d\",\"datePublished\":\"2024-01-19T21:04:10+00:00\",\"dateModified\":\"2024-06-21T09:09:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/\"},\"wordCount\":89,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gebro.es\\\/app\\\/uploads\\\/2024\\\/02\\\/sergi-aulina.jpg\",\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/\",\"name\":\"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gebro.es\\\/app\\\/uploads\\\/2024\\\/02\\\/sergi-aulina.jpg\",\"datePublished\":\"2024-01-19T21:04:10+00:00\",\"dateModified\":\"2024-06-21T09:09:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#\\\/schema\\\/person\\\/3fddcc01f48c9153acc62fa1fb9c3a78\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#primaryimage\",\"url\":\"https:\\\/\\\/gebro.es\\\/app\\\/uploads\\\/2024\\\/02\\\/sergi-aulina.jpg\",\"contentUrl\":\"https:\\\/\\\/gebro.es\\\/app\\\/uploads\\\/2024\\\/02\\\/sergi-aulina.jpg\",\"width\":384,\"height\":476},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/gebro.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/\",\"name\":\"Gebro Pharma\",\"description\":\"At Gebro Pharma we improve your health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gebro.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#\\\/schema\\\/person\\\/3fddcc01f48c9153acc62fa1fb9c3a78\",\"name\":\"mortensen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g\",\"caption\":\"mortensen\"},\"sameAs\":[\"http:\\\/\\\/gebro.es\\\/wp\"],\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/author\\\/mortensen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/","og_locale":"en_US","og_type":"article","og_title":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma","og_description":"El pasado mes de enero Sergi Aulinas, CEO de Gebro Pharma, realiz\u00f3 una entrevista con el peri\u00f3dico econ\u00f3mico Cinco D\u00edas. En ella cuenta un reciente relanzamiento de un producto de la compa\u00f1\u00eda, hecho posible gracias a un acuerdo coinversiones. Aulinas se\u00f1ala los desaf\u00edos en el acceso a nuevos medicamentos y aboga por una sanidad p\u00fablica [&hellip;]","og_url":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/","og_site_name":"Gebro Pharma","article_published_time":"2024-01-19T21:04:10+00:00","article_modified_time":"2024-06-21T09:09:21+00:00","og_image":[{"width":384,"height":476,"url":"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg","type":"image\/jpeg"}],"author":"mortensen","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mortensen","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#article","isPartOf":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/"},"author":{"name":"mortensen","@id":"https:\/\/gebro.es\/en\/#\/schema\/person\/3fddcc01f48c9153acc62fa1fb9c3a78"},"headline":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d","datePublished":"2024-01-19T21:04:10+00:00","dateModified":"2024-06-21T09:09:21+00:00","mainEntityOfPage":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/"},"wordCount":89,"commentCount":0,"image":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#primaryimage"},"thumbnailUrl":"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg","articleSection":["Press"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/","url":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/","name":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d - Gebro Pharma","isPartOf":{"@id":"https:\/\/gebro.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#primaryimage"},"image":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#primaryimage"},"thumbnailUrl":"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg","datePublished":"2024-01-19T21:04:10+00:00","dateModified":"2024-06-21T09:09:21+00:00","author":{"@id":"https:\/\/gebro.es\/en\/#\/schema\/person\/3fddcc01f48c9153acc62fa1fb9c3a78"},"breadcrumb":{"@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#primaryimage","url":"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg","contentUrl":"https:\/\/gebro.es\/app\/uploads\/2024\/02\/sergi-aulina.jpg","width":384,"height":476},{"@type":"BreadcrumbList","@id":"https:\/\/gebro.es\/en\/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/gebro.es\/en\/"},{"@type":"ListItem","position":2,"name":"Sergi Aulinas (Gebro Pharma): \u201cHay que actuar en el precio de los f\u00e1rmacos regulados esenciales para que sean rentables\u201d"}]},{"@type":"WebSite","@id":"https:\/\/gebro.es\/en\/#website","url":"https:\/\/gebro.es\/en\/","name":"Gebro Pharma","description":"At Gebro Pharma we improve your health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gebro.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/gebro.es\/en\/#\/schema\/person\/3fddcc01f48c9153acc62fa1fb9c3a78","name":"mortensen","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/30782690471a0c3faf99ab6c1377d2ae688b742c2471ce45429b9a10521b1569?s=96&d=mm&r=g","caption":"mortensen"},"sameAs":["http:\/\/gebro.es\/wp"],"url":"https:\/\/gebro.es\/en\/author\/mortensen\/"}]}},"_links":{"self":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/posts\/724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/comments?post=724"}],"version-history":[{"count":5,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/posts\/724\/revisions"}],"predecessor-version":[{"id":737,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/posts\/724\/revisions\/737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/media\/502"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/media?parent=724"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/categories?post=724"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/tags?post=724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}